Association of the aromatase gene alleles with BMD: Epidemiological and functional evidence

Journal of Bone and Mineral Research

Volumn 24, Issue 10, 2009, Pages 1709-1718

  Riancho, José A ^a   Sañudo, Carolina ^a   Valero, Carmen ^a   Pipaón, Carlos ^b   Olmos, José M ^a   Mijares, Verónica ^a   Fernández Luna, José L ^b   Zarrabeitia, María T ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Aromatase; CEBP ; Gene expression; Osteoporosis; Polymorphisms

Indexed keywords

AROMATASE; CCAAT ENHANCER BINDING PROTEIN BETA; LUCIFERASE;

ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; BONE DENSITOMETRY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DNA POLYMORPHISM; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXPRESSION VECTOR; FEMALE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENE LOCATION; GENOTYPE; HOMOZYGOTE; HUMAN; IN VITRO STUDY; INFORMED CONSENT; OSTEOBLAST; OSTEOPOROSIS; PATIENT SELECTION; POSTMENOPAUSE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSLATION INITIATION;

AGED; ALLELES; AROMATASE; BODY MASS INDEX; BONE DENSITY; CCAAT-ENHANCER-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EPIDEMIOLOGIC STUDIES; FEMALE; GENES, REPORTER; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LUCIFERASES; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE;

EID: 70349915716     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.090404     Document Type: Article

References (50)

1. Riggs BL, Khosla S, Melton LJ III 2002 Sex steroids and the construction and conservation of adult skeleton. Endocr Rev 23:279-302. (Pubitemid 34651948)
2. Ralston SH, de Crombrugghe B 2006 Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev 20:2492-2506. (Pubitemid 44396835)
3. Peacock M, Turner CH, Econs MJ, Foroud T 2002 Genetics of osteoporosis. Endocr Rev 23:303-326.
4. Brown LB, Streeten EA, Shapiro JR, McBride D, Shuldiner AR, Peyser PA, Mitchell BD 2005 Genetic and environmental influences on bone mineral density in pre- and postmenopausal women. Osteoporos Int 16:1849-1856. (Pubitemid 41790899)
5. Makovey J, Nguyen TV, Naganathan V, Wark JD, Sambrook PN 2007 Genetic effects on bone loss in peri- and postmenopausal women: A longitudinal twin study. J Bone Miner Res 22:1773-1780. (Pubitemid 351235144)
6. Kamat A, Hinshelwood MM, Murry BA, Mendelson CR 2002 Mechanisms in tissue-specific regulation of estrogen biosynthesis in humans. Trends Endocrinol Metab 13:122-128. (Pubitemid 36734002)
7. Simpson ER 2000 Role of aromatase in sex steroid action. J Mol Endocrinol 25:1549-1556.
8. Sebastian S, Bulun SE 2001 A highly complex organization of the regulatory region of the human CYP19 (aromatase) gene revealed by the human genome project. J Clin Endocrinol Metab 86:4600-4602. (Pubitemid 33020491)
9. McCloskey E 2006 Effects of third-generation aromatase inhibitors on bone. Eur J Cancer 42:1044-1051.
10. Bilezikian JP, Morishima A, Bell J, Grumbach MM 1998 Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency. J Clin Endocrinol Metab 339:599-603. (Pubitemid 28385657)
11. Herrmann BL, Saller B, Janssen OE, Gocke P, Bockisch A, Sperling H, Mann K, Broecker M 2002 Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene. J Clin Endocrinol Metab 87:5476-5484. (Pubitemid 36034347)
12. Miyaura C, Toda K, Inada M, Ohshiba T, Matsumoto C, Okada T, Ito M, Shizuta Y, Ito A 2001 Sex- and age-related response to aromatase deficiency in bone. Biochem Biophys Res Commun 280:1062-1068. (Pubitemid 32924448)
13. Riancho JA 2007 Polymorphisms in the CYP19 gene that influence bone mineral density. Pharmacogenomics 8:339-352. (Pubitemid 46585497)
14. Riancho JA, Zarrabeitia MT, Valero C, Sañudo C, Hernandez JL, Amado JA, Zarrabeitia A, Gonzalez-Macias J 2005 Aromatase gene and osteoporosis: Relationship of ten polymorphic loci with bone mineral density. Bone 36:917-925. (Pubitemid 40616027)
15. Riancho JA, Valero C, Naranjo A, Morales DJ, Sanudo C, Zarrabeitia MT 2007 Identification of an aromatase haplotype that is associated with gene expression and postmenopausal osteoporosis. J Clin Endocrinol Metab 92:660-665. (Pubitemid 46255311)
16. Valero C, Perez-Castrillon JL, Zarrabeitia MT, Hernandez JL, Alonso MA, Pino-Montes J, Olmos JM, Gonzalez-Macias J, Riancho JA 2008 Association of aromatase and estrogen receptor gene polymorphisms with hip fractures. Osteoporos Int 19:787-792. (Pubitemid 351652522)
17. Riancho JA, Valero C, Hernandez JL, Olmos JM, Paule B, Zarrabeitia A, Gonzalez-Macias J 2007 Biomechanical indices of the femoral neck estimated from the standard DXA output: Age- and sex-related differences. J Clin Densitom 10:39-45. (Pubitemid 46199282)
18. Riancho JA, Zarrabeitia MT, Valero C, Sanudo C, Mijares V, Gonzalez-Macias J 2006 A gene-to-gene interaction between aromatase and estrogen receptors influences bone mineral density. Eur J Endocrinol 155:53-59. (Pubitemid 44103375)
19. Pritchard JK, Stephens M, Donnelly P 2000 Inference of population structure using multilocus genotype data. Genetics 155:945-959. (Pubitemid 30397141)
20. Barrett JC, Fry B, Maller J, Daly MJ 2005 Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265. (Pubitemid 40202029)
21. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker Pl, Daly MJ, Sham PC 2007 PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575. (Pubitemid 47330214)
22. Nyholt DR 2004 A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74:765-769.
23. Zarrabeitia MT, Hernandez JL, Valero C, Zarrabeitia AL, Garcia-Unzueta MT, Amado JA, Gonzalez-Macias J, Riancho JA 2004 A common polymorphism in the 5′-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol 150:699-704. (Pubitemid 38786541)
24. Masi L, Becherini L, Gennari L, Amedei A, Colli E, Falchetti A, Farci M, Silvestri S, Gonnelli S, Brandi ML 2001 Polymorphism of the aromatase gene in postmenopausal Italian women: Distribution and correlation with bone mass and fracture risk. J Clin Endocrinol Metab 86:2263-2269. (Pubitemid 32472950)
25. Enjuanes A, Garcia-Giralt N, Supervia A, Nogues X, Ruiz-Gaspa S, Bustamante M, Mellibovsky L, Grinberg D, Balcells S, Diez-Perez A 2006 A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women. Bone 38:738-743.
26. Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM, Wierzbicki M, Fogelman I, Ralston SH, Hampson GN 2004 Polymorphisms in the P450 c17(17-hydroxylase/17,20-lyase) and P450 c19 (aromatase) genes: Association with serum sex steroid concentrations and bone mineral density in postmenopausal women. J Clin Endocrinol Metab 89:344-351. (Pubitemid 38183902)
27. Dick IM, Devine A, Prince RL 2005 Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Am J Physiol Endocrinol Metab 288:E989-E995. (Pubitemid 40547894)
28. Mendoza N, Moron FJ, Vazquez F, Quereda F, Saez ME, Martinez-Astorquiza T, Gonzalez-Perez A, Sanchez-Borrego R, Ruiz A 2006 Weighting the effect of CYP19A gene in bone mineral density of postmenopausal women. Bone 38:951-953. (Pubitemid 44523758)
29. Salmen T, Heikkinen AM, Mahonen A, Kroger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Maenpaa PH 2003 Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial. J Bone Miner Res 18:319-324.
30. Tofteng CL, Kindmark A, Brandstrom H, Abrahamsen B, Petersen S, Stiger F, Stilgren LS, Jensen JE, Vestergaard P, Langdahl BL, Mosekilde L 2004 Polymorphisms in the CYP19 and AR genes-relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study. Calcif Tissue Int 74:25-34. (Pubitemid 38166601)
31. Moron FJ, Mendoza N, Vazquez F, Molero E, Quereda F, Salinas A, Fontes J, Martinez-Astorquiza T, Sanchez-Borrego R, Ruiz A 2006 Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis. Bone 39:213-221.
32. Lorentzon M, Swanson C, Eriksson AL, Mellstrom D, Ohlsson C 2006 Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: The GOOD study. J Bone Miner Res 21:332-339. (Pubitemid 43265300)
33. Oz OK, Zerwekh JE, Graves K, Nanu L, Millsaps R, Simpson ER 2000 Bone has a sexually dimorphic response to aromatase deficiency. J Bone Miner Res 15:507-514. (Pubitemid 30134095)
34. Zhao Y, Nichols JE, Bulun SE, Mendelson CR, Simpson ER 1995 Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J Biol Chem 270:16449-16457.
35. Pant PV, Tao H, Beilharz EJ, Ballinger DG, Cox DR, Frazer KA 2006 Analysis of allelic differential expression in human white blood cells. Genome Res 16:331-339. (Pubitemid 43327503)
36. Wilkins JM, Southam L, Price AJ, Mustafa Z, Carr A, Loughlin J 2007 Extreme context specificity in differential allelic expression. Hum Mol Genet 16:537-546. (Pubitemid 46522616)
37. Haiman CA, Dossus L, Setiawan VW, Stram DO, Dunning AM, Thomas G, Thun MJ, Albanes D, Altshuler D, Ardanaz E, Boeing H, Buring J, Burtt N, Calle EE, Chanock S, Clavel-Chapelon F, Colditz GA, Cox DG, Feigelson HS, Hankinson SE, Hayes RB, Henderson BE, Hirschhorn JN, Hoover R, Hunter DJ, Kaaks R, Kolonel LN, Le Marchand L, Lenner P, Lund E, Panico S, Peeters PH, Pike MC, Riboli E, Tjonneland A, Travis R, Trichopoulos D, Wacholder S, Ziegler RG 2007 Genetic variation at the CYP19A1 locus predicts circulating estrogen levels but not breast cancer risk in postmenopausal women. Cancer Res 67:1893-1897. (Pubitemid 46424203)
38. Eriksson AL, Lorentzon M, Vandenput L, Labile F, Lindersson M, Syvanen AC, Orwoll ES, Cummings SR, Zmuda JM, Ljunggren O, Karlsson MK, Mellstrom D, Ohlsson C 2009 Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. J Clin Endocrinol Metab 94:1033-1041.
39. Watanabe M, Simpson ER, Pathirage N, Nakajin S, Clyne CD 2004 Aromatase expression in the human fetal osteoblastic cell line SV-HFO. J Mol Endocrinol 32:533-545. (Pubitemid 38584654)
40. McTernan PG, Anderson LA, Anwar AJ, Eggo MC, Crocker J, Barnett AH, Stewart PM, Kumar S 2002 Glucocorticoid regulation of p450 aromatase activity in human adipose tissue: Gender and site differences. J Clin Endocrinol Metab 87: 1327-1336. (Pubitemid 36121105)
41. Enjuanes A, Garcia-Giralt N, Surks MI, Nogues X, Mellibovsky L, Carbonell J, Grinberg D, Balcells S, Diez-Perez A 2003 Regulation of CYP19 gene expression in primary human osteoblasts: Effects of vitamin D and other treatments. Eur J Endocrinol 148:519-526. (Pubitemid 36622158)
42. Tanaka S, Haji M, Takayanagi R, Tanaka S, Sugioka Y, Nawata H 1996 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts. Endocrinology 137: 1860-1869. (Pubitemid 26133962)
43. Yanase T, Suzuki S, Goto K, Nomura M, Okabe T, Takayanagi R, Nawata H 2003 Aromatase in bone: Roles of vitamin D3 and androgens. J Steroid Biochem Mol Biol 86:393-397. (Pubitemid 37412577)
44. Fiorelli G, Frediani U, Martineti V, Franchi A, Gori F, Franceschelli F, Tanini A, Serio M, Brandi ML 1998 Aromatase expression and activity in the human leukaemic cell line FLG 29.1. J Steroid Biochem Mol Biol 66: 105-112. (Pubitemid 28366035)
45. Yang S, Fang Z, Suzuki T, Sasano H, Zhou J, Gurates B, Tamura M, Ferrer K, Bulun S 2002 Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): Decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase. J Clin Endocrinol Metab 87:2336-2345. (Pubitemid 34521528)
46. Ishikawa H, Fencki V, Marsh EE, Yin P, Chen D, Cheng YH, Reisterd S, Lin Z, Bulun SE 2008 CCAAT/enhancer binding protein beta regulates aromatase expression via multiple and novel cis-regulatory sequences in uterine leiomyoma. J Clin Endocrinol Metab 93:981-991.
47. Styrkarsdottir U, Halldorsson BV, Gretarsdottir S, Gudbjartsson DF, Walters GB, Ingvarsson T, Jonsdottir T, Saemundsdottir J, Center JR, Nguyen TV, Bagger Y, Gulcher JR, Eisman JA, Christiansen C, Sigurdsson G, Kong A, Thorsteinsdottir U, Stefansson K 2008 Multiple genetic loci for bone mineral density and fractures. N Engl J Med 358:2355-2365. (Pubitemid 351749159)
48. Kiel DP, Demissie S, Dupuis J, Lunetta KL, Murabito JM, Karasik D 2007 Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med Genet 8(Suppl 1):S14. (Pubitemid 351958747)
49. Richards JB, Rivadeneira F, Inouye M, Pastinen TM, Soranzo N, Wilson SG, Andrew T, Falchi M, Gwilliam R, Ahmadi KR, Valdes AM, Arp P, Whittaker P, Verlaan DJ, Jhamai M, Kumanduri V, Moorhouse M, van Meurs JB, Hofman A, Pols HA, Hart D, Zhai G, Kato BS, Mullin BH, Zhang F, Deloukas P, Uitterlinden AG, Spector TD 2008 Bone mineral density, osteoporosis, and osteoporotic fractures: A genome-wide association study. Lancet 371:1505-1512.
50. Klein RJ 2007 Power analysis for genome-wide association studies. BMC Genet 8:58.